Journal of Renal Nutrition
Volume 20, Issue 3 , Pages 199-208 , May 2010

Glutathione and Riboflavin Status in Supplemented Patients Undergoing Home Nocturnal Hemodialysis versus Standard Hemodialysis

This study was presented in part as a poster at the Experimental Biology Meeting, New Orleans, Louisiana, April 2009.

  • Jovil Kannampuzha, MSc

      Affiliations

    • The Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto, Ontario, Canada
    • Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Sandra M. Donnelly, MSc, MDCM, FRCP(C)

      Affiliations

    • The Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto, Ontario, Canada
    • Department of Nephrology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Philip A. McFarlane, MD, FRCP(C)

      Affiliations

    • The Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto, Ontario, Canada
    • Department of Nephrology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Christopher T. Chan, MD, FRCP(C)

      Affiliations

    • Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
    • Department of Nephrology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • James D. House, PhD

      Affiliations

    • Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • Paul B. Pencharz, MB, ChB, PhD, FRCP(C)

      Affiliations

    • Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada
    • Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
    • The Research Institute, The Hospital for Sick Children Toronto, Ontario, Canada
    • ,
  • Pauline B. Darling, MSc, PhD, RD

      Affiliations

    • Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
    • Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationAddress reprint requests to Dr. Pauline B. Darling, St. Michael's Hospital, Room 56D, 6th Floor Cardinal Carter Wing, Toronto, Ontario M5B 1W8, Canada.

References 

  1. Clermont G, Lecour S, Lahet J, et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res. 2000;47:618–623
  2. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int. 2001;59:407–414
  3. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678–1695
  4. Owada S, Tsukamoto T, Toyama K, et al. Erythrocyte redox state in hemodialyzed patients: glutathione and glutathione-related enzymes. J Artif Organs. 2001;4:8–18
  5. Alhamdani M. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant. 2005;20:124–128
  6. Jahoor F, Wykes LJ, Reeds PJ, et al. Protein-deficient pigs cannot maintain reduced glutathione homeostasis when subjected to the stress of inflammation. J Nutr. 1995;125:1462–1472
  7. Rahman SH, Srinivasan AR, Nicolaou A. Transsulfuration pathway defects and increased glutathione degradation in severe acute pancreatitis. Dig Dis Sci. 2009;54:675–682
  8. Stipanuk MH, Coloso RM, Garcia RA. Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocytes. J Nutr. 1992;122:420–427
  9. Mulherin DM, Thurnham DI, Situnayake RD. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996;55:837–840
  10. Friedman AN, Bostom AG, Levey AS, et al. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol. 2002;13:265–268
  11. Martincevic I, Goldstein M, McFarlane P, Jet al: Evidence for enhanced transsulphuration as a mechanism underlying lower hyperhomocysteinemia in patients undergoing home nocturnal hemodialysis. FASEB J 23:738.5, 2009 (abstract)
  12. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant. 1999;14:2835–2840
  13. D'Agostino RB. Tutorial in Biostatistics: Propensity Score Method for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  14. Courtney-Martin G, Rafii M, Wykes LJ, et al. Methionine-adequate cysteine-free diet does not limit erythrocyte glutathione synthesis in young healthy adult men. J Nutr. 2008;138:1–7
  15. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43–52
  16. Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for determination of total plasma homocysteine. Clin Chem. 1997;43:687–688
  17. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr. 1979;32:2143–2149
  18. Chung WY, Chung JK, Szeto YT. Plasma ascorbic acid: measurement, stability and clinical utility revisited. Clin Biochem. 2001;34:623–627
  19. Steiber AL, Kalantar-Zadeh K, Secker D, et al. Subjective global assessment in chronic kidney disease: a review. J Ren Nutr. 2004;14:191–200
  20. Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr. 2003;89:147–155
  21. Descombes E, Hanck AB, Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int. 1993;43:1319–1328
  22. The National Kidney Foundation of America: Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI). July 2007. Accessed August 7, 2008, from http://www.kidney.org/professionals/
  23. Suliman ME, Bárány P, Filho JCD, et al. Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphates in end stage renal disease. Nephrol Dial Transplant. 2002;17:1050–1056
  24. Suliman ME, Divino Filho JC, Bàràny P, et al. Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients. J Am Soc Nephrol. 1999;10:1287–1296
  25. Chauhan DP, Gupta PH, Nampoothiri MRN, et al. Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malondialdehyde in uremia. Clin Chim Acta. 1982;123:153–159
  26. Michelet F, Gueguen R, Leroy P, et al. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biochemical variables and life habits. Clin Chem. 1995;41:1509–1517
  27. Dass PD, Bermes EW, Holmes EW. Renal and hepatic output of glutathione in plasma and whole blood. Biochim Biophys Acta. 1992;1156:99–102
  28. Giustarini D, Milzani A, Dalle-Donne I, et al. Red blood cells as a physiological source of glutathione for extracellular fluids. Blood Cells Mol Dis. 2008;40:174–179
  29. Lu SC. Regulation of glutathione synthesis. Curr Top Cell Regul. 2000;36:95–116
  30. Reid M, Badaloo A, Forrester T, et al. In vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition. Am J Physiol. 2000;278:E405–E412
  31. Klarenbach S, Heidenheim P, Leitch R, et al. Reduced requirement for erythropoietin with Quotidian hemodialysis therapy. ASAIO J. 2002;48:57–61
  32. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001;16:335–340
  33. Annuk M, Zilmer M, Lind L, et al. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol. 2001;12:2747–2752
  34. Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42:286–294
  35. Richter A, Kuhlmann MK, Seibert E, et al. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant. 2008;23:2058–2063
  36. Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993;38:257–268
  37. Werb R, Clark WF, Lindsay RM, et al. Serum vitamin A levels and associated abnormalities in patients on regular dialysis treatment. Clin Nephrol. 1979;12:63–68
  38. Lucchi L, Banni S, Iannone A, et al. Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients. Artif Organs. 2005;29:413–418
  39. Bonnefont-Rousselot D, Jaudon MC, Issad B, et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1997;12:1399–1405
  40. Vahlquist A, Berne B, Berne C. Skin content and plasma transport of vitamin A and beta-carotene in chronic renal failure. Eur J Clin Invest. 1982;12:63–67

 Funding for this study was provided by a research grant from the Kidney Foundation of Canada.

PII: S1051-2276(09)00240-4

doi: 10.1053/j.jrn.2009.09.002

Journal of Renal Nutrition
Volume 20, Issue 3 , Pages 199-208 , May 2010

Article Tools

* Image Usage & Resolution